Research Article| Volume 34, ISSUE 3, P413-416, September 2007

An immunohistochemical profile of giant cell carcinoma of the larynx



      This report describes a case of a 62-year-old male with giant cell carcinoma of the larynx that presented as a neck mass and hoarseness.


      Case report, review of the world literature, and an immunohistochemical examination.


      Extended total laryngectomy and bilateral functional neck dissection were performed. Microscopical examination showed that the tumor was composed of solid masses of anaplastic small cells with hyperchromatic nuclei. There were multinucleated giant cells with huge nuclei, prominent nucleoli, and clear or eosinophylic cytoplasm. The diagnosis of giant cell carcinoma of the larynx was made. An immunohistochemical staining was applied to the case and tumor showed immunoreactivity with cytokeratin 8/18, cytokeratin 18, cytokeratin 19, vimentin, epithelial membrane antigen, S-100, cytokeratin 7 and did not show immunoreactivity with cytokeratin 10, cytokeratin 20, and carcinoembryogenic antigen.


      Giant cell carcinoma of the larynx is an extremely rare tumor the origin of which is not clearly understood. It is believed to be the counterpart of giant cell carcinoma of the lung in larynx. It is the sixth case reported in English literature and also the first case that is examined immunohistochemically. In conclusion, giant cell carcinoma of the larynx is confirmed to be a specific entity of simple epithelial origin and it is the counterpart of giant cell carcinoma of the lung.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ferlito A.
        Primary anaplastic giant cell adenocarcinoma of the larynx.
        J Laringol Otol. 1976; 90: 1053-1060
        • Ferlito A.
        • Friedmann I.
        • Recher G.
        Primary giant cell carcinoma of the larynx. A clinicopathologic study of four cases.
        ORL J Otolaryngol Related Spec. 1985; 47: 105-112
        • Ferlito A.
        Atypical forms of squamous cell carcinoma.
        in: Ferlito A. Neoplasms of the larynx. Churchill Livingstone, London/Madrid/Melbourne/Edinburg/PA1993: 135-168
        • El-Jabbour J.N.
        • Ferlito A.
        • Friedmann I.
        Salivary gland neoplasms.
        in: Ferlito A. Neoplasms of the larynx. Churchill Livingstone, London/Madrid/Melbourne/Edinburg/PA1993: 231-264
        • Chejfec G.
        • Candel A.
        • Jansson D.S.
        • Warren W.H.
        • Koukoulis G.K.
        • Gould J.E.
        • et al.
        Immunohistochemical features of giant cell carcinoma of the lung: Patterns of expression cytokeratins, vimentin, and the mucinous glycoprotein recognised by monoclonal antibody A-80.
        Ultrastruct Pathol. 1991; 15: 131-138
        • Addis B.J.
        • Dewar A.
        • Thurlow N.P.
        Giant cell carcinoma of the lung immunhistochemical and ultrastructural evidence of dedifferentiation.
        J Pathol. 1998; 155: 231-240
        • Rossi G.
        • Cavazza A.
        • Sturm N.
        • Migaldi M.
        • Facciolongo N.
        • Longo L.
        • et al.
        Pulmonary carcinomas with pleomorphic sarcomatoid, or sarcomatous elements.
        Am J Surg Pathol. 2003; 27: 311-324
        • Kodama T.
        • Shimosato Y.
        • Koide T.
        • Watanabe S.
        • Teshima S.
        Large cell carcinoma of the lung-ultrastructural and immunohistochemical studies.
        Jpn J Clin Oncol. 1985; 15: 431-441
        • Lee I.
        • Radosevich J.A.
        • Chejfec G.
        • Ma Y.X.
        • Warren W.H.
        • Rosen S.T.
        • et al.
        Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
        Am J Pathol. 1986; 123: 497-507
        • Moll R.
        • Lowe A.
        • Laufer J.
        • Franke W.W.
        Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
        Am J Pathol. 1992; 140: 427-447
        • Roh M.S.
        • Hong S.H.
        Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
        J Korean Med Sci. 2002; 17: 512-517
        • Chu P.
        • Wu E.
        • Weiss L.M.
        Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
        Mod Pathol. 2000; 13: 962-972
        • Pilch B.Z.
        Larynx and hypopharynx.
        in: Pilch B.Z. Head and neck surgical pathology. Lippincot Williams & Wilkins, Philadelphia, New York, Baltimore, PA2001: 230-283
        • Raveglia F.
        • Mezzetti M.
        • Panigalli T.
        • Furia S.
        • Giuliani L.
        • Conforti S.
        • et al.
        Personal experience in surgical management of pulmonary pleomorphic carcinoma.
        Ann Thorac Surg. 2004; 78: 1742-1747